2024/10/18 22:02:04 | |
---|---|
Price | |
66.62 EUR | |
Difference | 0.63% (0.42) |
ISIN | US8064071025 |
Symbol | HSIC |
Exchange | Tradegate |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 8,470 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 66.52 EUR (50) |
Ask (Ask size) | 66.72 EUR (50) |
Open | 66.62 EUR |
High | 66.62 EUR |
Low | 66.62 EUR |
Close (prev. day) | 66.20 EUR |
VWAP | 66.28 EUR |
Volume (pcs) | - |
Trading volume | - |
Number of trades | 1 |
Last size | - |
Related Futures | - |
Related Options | - |
Date | Headline | Download | |
2024/10/08 | Global Strategy 4Q 2024 | ||
2024/09/27 | Global Equity Ratings | ||
2024/09/11 | Global Equity Ratings | ||
2024/09/05 | Global Equity Ratings | ||
2024/08/12 | Global Equity Ratings |
2024/10/18 22:02:04 | |
---|---|
Price | |
66.62 EUR | |
Difference | 0.63% (0.42) |
ISIN | US8064071025 |
Symbol | HSIC |
Exchange | Tradegate |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 8,470 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 66.52 EUR (50) |
Ask (Ask size) | 66.72 EUR (50) |
Open | 66.62 EUR |
High | 66.62 EUR |
Low | 66.62 EUR |
Close (prev. day) | 66.20 EUR |
VWAP | 66.28 EUR |
Volume (pcs) | - |
Trading volume | - |
Number of trades | 1 |
Last size | - |
6m | 1Y | 3Y | |
Perf (%) | +0.64% | -1.90% | -0.81% |
Perf (abs.) | +0.42 | -1.28 | -0.54 |
Beta | 0.44 | 0.57 | 0.62 |
Volatility | 26.42 | 24.62 | 23.85 |
Ø price 5 days | Ø volume 5 days (pcs.) | 65.44 EUR (2) |
Ø price 30 days | Ø volume 30 days (pcs.) | 63.92 EUR (61) |
Ø price 100 days | Ø volume 100 days (pcs.) | 63.12 EUR (101) |
Ø price 250 days | Ø volume 250 days (pcs.) | 65.37 EUR (121) |
YTD High | date | 74.96 EUR (2024/02/26) |
YTD Low | date | 58.26 EUR (2024/08/06) |
52 Weeks High | date | 74.96 EUR (2024/02/26) |
52 Weeks Low | date | 56.50 EUR (2023/11/13) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Xetra | 2023/10/25 | 17:35 | 63.84 EUR | 0.00 | 2 |
Vienna Stock Exchange | 2024/10/18 | 17:32 | 66.12 EUR | 0.00 | 5 |
Tradegate | 2024/10/18 | 22:02 | 66.62 EUR | 0.00 | 1 |
Stuttgart | 2024/10/18 | 21:31 | 66.28 EUR | 0.00 | 8 |
Nasdaq | 2024/10/18 | 22:00 | 72.39 USD | 49.62 | 13,490 |
Munich | 2024/10/18 | 08:00 | 66.00 EUR | 0.00 | 2 |
London Stock Exchange | 2024/09/10 | 15:30 | 68.51 USD | 0.10 | 1 |
Hanover | 2024/10/18 | 17:25 | 66.14 EUR | 0.00 | 4 |
Hamburg | 2024/10/18 | 17:25 | 66.14 EUR | 0.00 | 4 |
Frankfurt | 2024/10/18 | 08:03 | 65.84 EUR | 0.00 | 2 |
Duesseldorf | 2024/10/18 | 19:31 | 66.42 EUR | 0.00 | 7 |
Berlin | 2024/10/18 | 08:08 | 65.98 EUR | 0.00 | 2 |
HENRY SCHEIN INC. |
- - |
135 Duryea Road - 11747 Melville |
Telefon: +1-631-843-5500 |
Fax: +-631-843-5658 |
E-mail: - |
Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, laboratory, small and large equipment repair services, branded and generic pharmaceuticals, vaccines, surgical, diagnostic tests, infection-control products, and vitamins. The Technology and Value-Added Services segment offers financial on a non-recourse basis, network, and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY. |
Bradley Sheares | Member of Board of Directors |
Reed Tuckson | Member of Board of Directors |
Anne Margulies | Member of Board of Directors |
Carol Raphael | Member of Board of Directors |
Carole Faig | Member of Board of Directors |
Deborah Derby | Member of Board of Directors |
Joseph Herring | Member of Board of Directors |
Kurt Kuehn | Member of Board of Directors |
Mark Mlotek | Member of Board of Directors |
Mohamad Ali | Member of Board of Directors |
Philip Laskaway | Member of Board of Directors |
Scott Serota | Member of Board of Directors |
Stanley M. Bergman | Chairman of Managing Board |
Brad Connett | Member of Executive Committee |
Christopher Pendergast | Member of Executive Committee |
David Brous | Member of Executive Committee |
James Mullins | Member of Executive Committee |
James P. Breslawski | Member of Executive Committee |
Leigh Benowitz | Member of Executive Committee |
Lorelei McGlynn | Member of Executive Committee |
Mark E. Mlotek | Member of Executive Committee |
Michael S. Ettinger | Member of Executive Committee |
René Willi | Member of Executive Committee |
Ronald N. South | Member of Executive Committee |
Trinh Clark | Member of Executive Committee |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer